Radiopharmaceuticals are unique medicinal formulations containing radioisotopes/radionuclides/ radioactive isotopes bond to an organic molecule. Radioisotopes serve as beneficial source of ionizing radiation and are used in major clinical areas for diagnosis and/or therapy. Radioisotopes are mainly produced in nuclear reactors or in cyclotrons. Radioisotopes emitting gamma rays are used for diagnostic (imaging) purposes where the radiation has to escape the body before being detected by a specific device (SPECT/PET cameras). Whereas, radioisotopes emitting short range particles (alpha, beta or auger electron) are used for therapy owing to their power to lose all their energy over a very short distance, thereby causing a lot of local damage. This property is used for therapeutic purposes in cancer cells destruction, pain treatment in palliative care for bone cancer or arthritis etc.
Market - Headwinds & Tailwinds
The global radiopharmaceuticals market is mainly driven by rising prevalence of various chronic diseases, increasing awareness for early diagnosis of the diseases, advancements in molecular imaging techniques, and government initiatives to promote radiopharmaceuticals development. Furthermore, robust pipeline of products is also expected to play a pivotal role in contributing to the growth of the market globally. However, lack of harmonized regulatory guidelines is likely to restrain the market growth to a certain extent.
The global radiopharmaceuticals market has been analyzed from three perspectives: Type, Application and Region.
Based on type, the market has been segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. The diagnostic radiopharmaceuticals are further categorized into SPECT radiopharmaceuticals and PET radiopharmaceuticals. Whereas, therapeutic radiopharmaceuticals are further categorized into alpha emitters, beta emitters, and auger electron (AE) emitters. The diagnostic radiopharmaceuticals segment accounted for the largest share in the market. Diagnostic radiopharmaceuticals, also known as functional imaging or molecular imaging, enables physicians to accurately diagnose and stage complex diseases, such as neurological and cardiovascular disorders in early stages. Majority of radiopharmaceuticals are used for medical diagnostic purposes, and generally do not have concrete pharmacological effects on the body.
Based on application, the radiopharmaceuticals market has been segmented into cardiovascular disorders, oncological disorders, neurological disorders, orthopedics disorders and others (endocrine disorders, respiratory disorders, gastrointestinal diseases, etc.). The oncological disorders segment holds the largest share in the market. Factors such as increasing incidences of cancer coupled with the growing geriatric population are playing a key role in propelling the growth of this segment. Moreover, increasing research activities for the development of radiopharmaceuticals that can be utilized for the diagnosis or treatment of cancer and new product launches by market players are also driving the growth of the oncological disorders segment.
Based on region, the global radiopharmaceuticals market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the radiopharmaceuticals market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to the presence of prominent players, increasing incidences of conditions such as cancer, cardiovascular diseases, neurological diseases, orthopedic diseases and adoption of advanced technologies for disease diagnosis & treatment.
The radiopharmaceuticals market is marked by presence of prominent players such as Bayer, General Electric, Cardinal Health, Lantheus Medical Imaging, Inc., Bracco Diagnostic Inc., CURIUM, Nordion (Canada) Inc., Eczacıbaşı-Monrol, Advanced Accelerator Applications, SHINE Medical Technologies, LLC. Other players operating in the market NorthStar Medical Technologies, Eckert & Ziegler, Jubilant Radiopharma, Global Medical Solutions, among others.
|Market Size Period||2018-2031|
|Market Segments||Asessment of Radiopharmaceuticals Market By:
|Geographic Scope||• North America
◦ Rest of Europe (RoE)
• Asia Pacific
◦ Rest of Asia Pacific (RoAPAC)
• Rest of the World
◦ Latin America
◦ Middle East & Africa
|Companies Covered||Bayer, General Electric, Cardinal Health, Lantheus Medical Imaging, Inc., Bracco Diagnostic Inc., CURIUM, Nordion (Canada) Inc., Eczacıbaşı-Monrol, Advanced Accelerator Applications, SHINE Medical Technologies, LLC., NorthStar Medical Technologies, Eckert & Ziegler, Jubilant Radiopharma, Global Medical Solutions, among others.|
1 RESEARCH ENVELOPE
1.1 Market Classification
1.2 Scope of the Study
1.2.1 Timeline Considered for Market Study
· Historic Years – 2018 & 2019
· Base Year – 2020
· Projected Years – 2021 to 2031
1.3 Currency Used in the Report
2 RESEARCH METHODOLOGY
2.1 Research Approach
2.2 Data Collection Methodology
2.3 Data Sources
2.3.1 Secondary Sources
2.3.2 Primary Sources
2.4 Market Crackdown Methodology
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Forecasting Model
2.6 Limitations and Assumptions for Study
3 HEADWINDS & TAILWINDS ASSESSMENT
4 MARKET OPPORTUNITIES ASSESSMENT
5 PREMIUM INSIGHTS
5.1 Key Market Trends
5.2 Key Players & Their Competitive Positioning (2020)
5.3 COVID-19 Impact Assessment
5.4 Pipeline Assessment
6 GLOBAL RADIOPHARMACEUTICALS MARKET - ANALYSIS & FORECAST, BY TYPE
6.1 Diagnostic Radiopharmaceuticals
6.1.1 SPECT Radiopharmaceuticals
6.1.2 PET Radiopharmaceuticals
6.2 Therapeutic Radiopharmaceuticals
6.2.1 Alpha Emitters
6.2.2 Beta Emitters
6.2.3 Auger Electron (AE) Emitters
7 GLOBAL RADIOPHARMACEUTICALS MARKET - ANALYSIS & FORECAST, BY APPLICATION
7.1 Cardiovascular Disorders
7.2 Oncological Disorders
7.3 Neurological Disorders
7.4 Orthopedics Disorders
7.5 Others (Endocrine Disorders, Respiratory Disorders, Gastrointestinal Diseases, etc.)
8 GLOBAL RADIOPHARMACEUTICALS MARKET - ANALYSIS & FORECAST, BY REGION
8.1 North America Radiopharmaceuticals Market
8.1.1 North America Radiopharmaceuticals Market, By Country
8.1.2 North America Radiopharmaceuticals Market, By Type
8.1.3 North America Radiopharmaceuticals Market, By Application
8.2 Europe Radiopharmaceuticals Market
8.2.1 Europe Radiopharmaceuticals Market, By Country/Region
22.214.171.124 Rest of Europe (ROE)
8.2.2 Europe Radiopharmaceuticals Market, By Type
8.2.3 Europe Radiopharmaceuticals Market, By Application
8.3 Asia Pacific Radiopharmaceuticals Market
8.3.1 Asia Pacific Radiopharmaceuticals Market, By Country/Region
126.96.36.199 Rest of Asia Pacific (RoAPAC)
8.3.2 Asia Pacific Radiopharmaceuticals Market, By Type
8.3.3 Asia Pacific Radiopharmaceuticals Market, By Application
8.4 Rest of the World (RoW) Radiopharmaceuticals Market
8.4.1 Rest of the World Radiopharmaceuticals Market, By Region
188.8.131.52 Latin America
184.108.40.206 Middle East & Africa
8.4.2 Rest of The World Radiopharmaceuticals Market, By Type
8.4.3 Rest of The World Radiopharmaceuticals Market, By Application
9 COMPANY PROFILES
9.1.1 Business Overview
9.1.2 Financial Metrics*
9.1.3 Product Portfolio
9.1.4 Key Developments
9.2 General Electric
9.3 Cardinal Health
9.4 Lantheus Medical Imaging, Inc.
9.5 Bracco Diagnostic Inc.
9.7 Nordion (Canada) Inc.
9.9 Advanced Accelerator Applications
9.10 SHINE Medical Technologies, LLC
*Insights on financial metrics is subject to availability of information in the public domain
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...